Biocodex is a family-owned pharmaceutical company that has evolved from a pioneering French microbiota company in the 1950s to now being an international player in the healthcare industry. With a presence in 115 countries worldwide, Biocodex provides innovative healthcare solutions to patients globally. Founded in 1953, Biocodex initially introduced the first probiotic yeast strain for human medicine, Saccharomyces boulardii CNCM I-745®.

Today, the company offers a diverse range of products in three key areas: microbiota care, women's health, and orphan diseases. The company is driven by a mission to provide innovative healthcare solutions to women, men, and children across the globe. With 1,664 dedicated employees, Biocodex is committed to meeting the healthcare needs of millions of patients around the world.

Their expertise is evident in their development and marketing of healthcare products, emphasizing microbiota care, women's health, and orphan diseases. Biocodex's success is rooted in shared values, including the courage to innovate, collaboration, fairness in relationships, and caring for the ecosystem. With headquarters in France, the company operates through 17 subsidiaries and a network of long-term partners in more than 115 countries.

Overall, Biocodex's commitment to innovation, patient care, and global presence positions them as a leading multinational pharmaceutical company in providing healthcare solutions